-
Study assessing the efficacy and safety of durvalumab plus olaparib plus fulvestrant in selected metastatic or locally advanced ER-positive, HER2-negative breast cancer patients.
Study
EGAS50000001166
-
Analysis of Large Cell Neuroendocrine Carcinoma Expressing HNF4alpha Using WGS
Study
JGAS000732
-
WES analysis of tumor samples from ER+ breast cancer patients treated with CDK4/6 inhibitor
Dataset
EGAD50000000622
-
Transcriptome analysis of iPSC-derived hepatocytes from Wilson's Disease patients and healthy controls
Study
JGAS000382
-
Project for Development of Innovative Research on Cancer Therapeutics;Shuttle system between petient-derived xenograft and ex vivo culture for innovative platform of evaluating drug sensitivity.
Study
JGAS000089
-
A single-cell atlas of the early COPD lung
Study
EGAS50000000720
-
Transcriptomic profiling of myeloid cells from secondary lymphoid organs (lymph nodes and tonsils) from lymphoma patients and controls.
Study
EGAS50000001135
-
Genomic characterization of germ-cell tumors in childhood
Study
EGAS50000000619
-
The genomic landscape of large and small tumors in early-onset prostate cancer patients
Study
EGAS00001000383
-
ISCAPE V(D)J libraries from HA-specific single memory B cells of four Influenza A exposed individuals
Dataset
EGAD50000002019